Immunotherapies for the Effective Treatment of Primary Autoimmune Cerebellar Ataxia: a Case Series

Jiao Li,Bo Deng,Wenli Song,Keru Li,Jingwen Ai,Xiaoni Liu,Haocheng Zhang,Yi Zhang,Ke Lin,Guofu Shao,Chunfeng Liu,Wenhong Zhang,Xiangjun Chen,Yanlin Zhang

DOI: https://doi.org/10.1007/s12311-022-01496-z

2022-01-01

Abstract:Primary autoimmune cerebellar ataxia (PACA) is an idiopathic sporadic cerebellar ataxia that is thought to be immune-mediated but lacks biomarkers or a known cause. Here, we report two cases of immune-mediated cerebellar ataxia that responded favorably to immunotherapy, in which tissue-based indirect immunofluorescence test for serum or cerebrospinal fluid (CSF) samples yielded positive results. Case 1 was a 78-year-old man who presented with subacute progressive gait ataxia with truncal instability and dysarthria in response to steroids. Case 2 was a 62-year-old man who presented with relapses and remissions of acute progressive cerebellar ataxia occurring 1-2 times per year. Despite a favorable response to steroid treatment, he relapsed repeatedly in the absence of long-term immunosuppression. In the case of "idiopathic" cerebellar ataxia, immune-mediated causes should be investigated, and immunotherapy may have therapeutic effects.